SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950129-08-001678
Filing Date
2008-03-13
Accepted
2008-03-13 17:22:30
Documents
1
Group Members
ALBERT & MARGARET ALKEK FOUNDATIONALKEK & WILLIAMS VENTURES LTD.CHASWIL, LTD.DANIEL C. ARNOLDDLD FAMILY INVESTMENTS, LLCJOE M. BAILEYRANDA DUNCAN WILLIAMSSCOTT B. SEAMAN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13D h54952asc13dza.htm SC 13D/A 130470
  Complete submission text file 0000950129-08-001678.txt   132966
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Subject) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81104 | Film No.: 08686960
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1221 MCKINNEY, SUITE 4525 HOUSTON TX 77010
Business Address 1221 MCKINNEY, SUITE 4525 HOUSTON TX 77010 713-951-0019
Albert & Margaret Alkek Foundation (Filed by) CIK: 0001359867 (see all company filings)

IRS No.: 760491186 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D/A